Targeting tumor behavior may lead to new liver cancer drugs

Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.

If you want to include this story in your blog, copy and paste this formatted text: